ST
MYGN icon

Spot Trading’s Myriad Genetics MYGN Stock Holding History

Spot Trading’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$774K Sell
21,400
-19,700
-48% -$562K 0.01% 1328
2017
Q2 		$1.06M Buy
+41,100
New +$872K 0.02% 1052
2016
Q4 		– Sell
-27,500
Closed -$566K – 3018
2016
Q3 		$566K Hold
27,500
– – 0.01% 1457
2016
Q2 		$842K Buy
+27,500
New +$955K 0.01% 1252
2015
Q4 		– Sell
-88,800
Closed -$3.33M – 3896
2015
Q3 		$3.33M Buy
88,800
+69,900
+370% +$2.48M 0.03% 754
2015
Q2 		$642K Hold
18,900
– – 0.01% 1943
2015
Q1 		$669K Sell
18,900
-4,900
-21% -$175K 0.01% 1889
2014
Q4 		$811K Sell
23,800
-51,500
-68% -$1.83M 0.01% 2018
2014
Q3 		$2.9M Sell
75,300
-700
-0.9% -$26.1K 0.01% 1284
2014
Q2 		$2.96M Sell
76,000
-71,600
-49% -$2.66M 0.01% 1327
2014
Q1 		$5.05M Buy
147,600
+86,900
+143% +$2.69M 0.03% 848
2013
Q4 		$1.27M Sell
60,700
-15,900
-21% -$402K 0.01% 1801
2013
Q3 		$1.8M Sell
76,600
-102,800
-57% -$2.92M 0.01% 1454
2013
Q2 		$4.82M Buy
+179,400
New +$5.2M 0.03% 742

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Spot Trading's MYGN Position: Q4 2016 in Review

Spot Trading sold out of Myriad Genetics (MYGN) in Q4 2016, closing a stake of 1,101 shares — an estimated $23K sold.

Spot Trading first reported a position in MYGN in Q3 2013 and held it in 8 quarters. The position peaked at $5.33M in Q3 2013. 223 funds tracked by Wall St. Rank hold MYGN as of Q4 2016.

  • Spot Trading reported no remaining Myriad Genetics position as of Q4 2016 after selling out during the quarter.
  • Spot Trading sold 1,101 Myriad Genetics shares in Q4 2016, an estimated $23K.
  • Spot Trading first reported a position in Myriad Genetics in Q3 2013 and held it in 8 quarters.
  • Spot Trading's Myriad Genetics position peaked at $5.33M in Q3 2013.
  • 223 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2016.

Based on Spot Trading's 13F filing for Q4 2016, filed 7 Feb 2017.